These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. Murnane PM, Heffron R, Ronald A, Bukusi EA, Donnell D, Mugo NR, Were E, Mujugira A, Kiarie J, Celum C, Baeten JM, Partners PrEP Study Team. AIDS; 2014 Jul 31; 28(12):1825-30. PubMed ID: 24785951 [Abstract] [Full Text] [Related]
4. Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques. Radzio J, Hanley K, Mitchell J, Ellis S, Deyounks F, Jenkins L, Heneine W, García-Lerma JG. J Acquir Immune Defic Syndr; 2014 Dec 01; 67(4):365-9. PubMed ID: 25202923 [Abstract] [Full Text] [Related]
9. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, Baeten JM, Partners PrEP Study Team. AIDS; 2013 Aug 24; 27(13):2155-60. PubMed ID: 24384592 [Abstract] [Full Text] [Related]
12. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial. Polis CB, Nakigozi GF, Nakawooya H, Mondo G, Makumbi F, Gray RH, Members of the Rakai Health Sciences Program Sayana Press study team. Contraception; 2014 May 24; 89(5):385-95. PubMed ID: 24332432 [Abstract] [Full Text] [Related]
16. Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate. Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR. AIDS Res Hum Retroviruses; 2019 Mar 24; 35(3):236-246. PubMed ID: 30585733 [Abstract] [Full Text] [Related]
18. Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K, Nair G, Chappell C, Kiweewa FM, Kabwigu S, Naidoo L, Jeenarain N, Marzinke M, Soto-Torres L, Brown ER, Baeten JM. J Acquir Immune Defic Syndr; 2017 Oct 01; 76(2):e47-e51. PubMed ID: 28542081 [Abstract] [Full Text] [Related]
19. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities. Kourtis AP, Haddad L, Tang J, Chinula L, Hurst S, Wiener J, Ellington S, Nelson JA, Corbett A, De Paris K, King CC, Hosseinipour M, Hoffman IF, Jamieson DJ. Contemp Clin Trials; 2017 Jan 01; 52():27-34. PubMed ID: 27836505 [Abstract] [Full Text] [Related]
20. Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships. Ngure K, Velloza J, Patel RC, Mugo NR, Bukusi EA, Haberer JE, Odoyo J, Celum C, Baeten JM, Heffron R. Int J STD AIDS; 2020 Nov 01; 31(13):1263-1271. PubMed ID: 32998640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]